Clinical Trial Update: Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NIRT 2-HNC) [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant immunoradiotherapy trial for head and neck cancer is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: Providence Health & Services | Conditions: Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING